Postdoc to join our lab as part of our Wellcome Discovery Award team with WithersLab and Clatworthy Lab

Apply below! (closing date May 10th)

ucl.ac.uk/work-at-ucl/se…

We’re very excited to invite you to the UK Society for Behavioural Medicine Cancer SIGs first journal club event, taking place online next week.

Sign up following the link below. Members & non-members welcome 😃

Details of the journal can be found in the registration link!

Thanks for sharing our paper on the very low risk of T cell malignancies driven by insertional mutagenesis in a paediatric/young adult CART setting. Impt to contrast with the non-negligible risk of secondary myeloid malignancies seen with CART as with any anti-leukaemic therapy…

Optimising brain age estimation through transfer learning: A suite of models for improved performance and generalisability in a clinical setting Biomedical Engineering & Imaging Sciences Thomas C Booth
ncbi.nlm.nih.gov/pmc/articles/P…

Barts Cancer Centre director Professor Tom Powles has been named among the 100 most influential people in global health care by TIME magazine for his groundbreaking approach to tackling bladder cancer.

orlo.uk/VbH67

We would be honoured if you would join us 13-15 May 2024 for #pint24
Come to the dark side, we have science talks!

🗣 450 events
📍 +40 locations
🎫 Programme and tickets: pintofscience.co.uk

#MayThe4thBeWithYou #StarWarsDay

We are hugely proud and delighted that Tom Powles has been named in #TIME100HEALTH of the 100 most influential people in global health this year for his transformative research on bladder cancer. TIME, Barts Cancer Institute (Queen Mary) , Barts Health qmul.ac.uk/media/news/202…

Profs Mark Emberton & Caroline Moore UCL Div of Surgery will be two of six lead researchers on @ProstateCancerUK's £42million screening trial. The biggest prostate cancer trial in 20 years aims to transform diagnosis and save thousands more men each year
ucl.ac.uk/news/2024/may/…

We have 2 MRC DPFS-funded posts to join our lovely team & build on exciting findings to help us harness cross-reactive mucosal immunity for a pan-cornavirus vaccine
Job details: Research Fellow (ucl.ac.uk)
Job details: Research Assistant (ucl.ac.uk)

See our recent review, in a special issue edited by Stefano Santaguida from Joana Andrade Annie Dinky Gallagher and Jovanna Maharaj 'Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies' link.springer.com/article/10.100…

Tickets to #PostdocFutures24 are now available to all cancer postdocs🚨

Learn about CRUK training and funding opportunities, including a new programme supporting postdocs transitioning to independence.

Tickets refundable after attendance bit.ly/421tfqU

Another exciting innovation from the AMR Research Lab KCL in collaboration with Khuloud Al-Jamal FRPharmS FRSC . King's College London has filed a patent on new generation payloads for antibody drug conjugates to treat cancer. The work was conducted by Mahbub Hasan during his PhD funded by CSC in the UK

We’re delighted to share that His Majesty King Charles III will be our new Patron.

This is an exciting time for us and for cancer research. We’re looking forward to the opportunities His Majesty’s Patronage will bring, and know this support will help progress our mission to…

Sara Ghorashian Sara Ghorashian took us today Sara Ghorashian Sara Ghorashian shared her research on optimizing CAR-T therapies for acute leukemia.
UCL Great Ormond Street Institute of Child Health

J.P. Martinez-Barbera discussed how senescence is involved in the pathogenesis of various tumours and cancers in his presentation.
UCL Great Ormond Street Institute of Child Health

Early exposure in life to antigens and consequently early immune response influences the rate of preleukemic becoming leukaemia cells? This question and more were answered by Tariq enver in his presentation Initiation and Evolution of Childhood Leukaemia UCL Cancer Institute

In his talk, Kasper Fugger presented a model on how circulating modified nucleotides are detoxified in cells to safeguard genome stability
CRUK RadNet City of London UCL Cancer Institute The Crick

Great talk from Marnix Jansen where he exposed how incremental mismatch repair mutations drive intratumor heterogeneity
UCL Cancer Institute CRUKCOLcentre

Great opening for the UCL Cancer Domain symposium with Charles Swanton. Charlie took us on a cancer evolution journey through 10 years of TRACERx study UCL Cancer Institute The Crick Science and Innovation at Cancer Research UK CRUKCOLcentre Mariam Jamal-Hanjani Nnennaya Kanu Nicholas McGranahan Quezada Lab

It was our pleasure to join Their Majesties The King and Queen today at UCLH.

We're sure their visit will have meant a lot to the staff, patients and our colleagues who had the chance to meet them.

Thank you for your ongoing support.💚